Inventors: Gaikwad Anil Bhanudas

Novel pharmacological interventions targeting chronic kidney disease are being explored utilizing inodilators, ET-1A antagonists, and bisphosphonates that are currently approved for clinical use, reflecting a drug repurposing strategy. This approach seeks to leverage the therapeutic properties of these drugs in a new context to combat the complexities of chronic kidney...